GridAI Technologies (GRDX) vs TransCode Therapeutics (RNAZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GridAI Technologies (GRDX) has outperformed TransCode Therapeutics (RNAZ) over the past year, gaining 0.0% versus a loss of 85.6%. Over five years, GRDX leads with a -100.0% price change compared with -100.0% for RNAZ. GridAI Technologies is the larger company by market cap ($31.0 million vs $30.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRDX | RNAZ |
|---|---|---|
| Share price | $4.35 | $1.79 |
| Market cap | $31.02M | $30.31M |
| 1-day change | +5.60% | +1.70% |
| YTD return | -11.59% | -74.23% |
| 1-year return | 0.00% | -85.60% |
| 5-year return | -99.99% | -100.00% |
| EPS (TTM) | $-5.65 | $-52.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.93 | $15.94 |
| 52-week low | $1.87 | $1.52 |
| Distance from 52-week high | -37.22% | -88.77% |
| Average volume | 101.84K | 50.80K |
| Shares outstanding | 7.13M | 16.93M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRDX has outperformed RNAZ by 85.6 percentage points over the past year.
GRDX vs RNAZ FAQ
Which is bigger, GridAI Technologies or TransCode Therapeutics?
GridAI Technologies (GRDX) is larger, with a market capitalization of $31.02M compared with $30.31M for TransCode Therapeutics (RNAZ).
Which stock has performed better over the past year, GRDX or RNAZ?
GRDX returned 0.00% over the past 12 months, compared with -85.60% for RNAZ (price return, excluding dividends). Past performance does not predict future results.
Are GridAI Technologies and TransCode Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.